BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22217907)

  • 1. Improving survival following surgery for pancreatic ductal adenocarcinoma--a ten-year experience.
    Hoem D; Viste A
    Eur J Surg Oncol; 2012 Mar; 38(3):245-51. PubMed ID: 22217907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
    Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical treatment of pancreatic carcinoma. Our experience].
    Testi W; Coratti A; Tani F; Lorenzi M; Poggialini M; Genovese A; Spagnulo M; Terreni C; Picchianti D; Stefanoni M; Mancini S
    Minerva Chir; 2000; 55(7-8):505-12. PubMed ID: 11140104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a pylorus-preserving pancreatoduodenectomy for pancreatic cancer: a comparison with results of the Whipple procedure.
    Takada T; Yasuda H; Amano H; Yoshida M; Ando H
    Hepatogastroenterology; 1997; 44(18):1536-40. PubMed ID: 9427018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
    Storkholm JH; Hansen CP
    Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
    Marangos IP; Buanes T; Røsok BI; Kazaryan AM; Rosseland AR; Grzyb K; Villanger O; Mathisen Ø; Gladhaug IP; Edwin B
    Surgery; 2012 May; 151(5):717-23. PubMed ID: 22284762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreaticoduodenectomy for periampullary adenocarcinoma.
    Andersen HB; Baden H; Brahe NE; Burcharth F
    J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
    Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
    World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
    Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
    J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for mucin-producing pancreatic tumor.
    Yasuda H; Takada T; Amano H; Yoshida M
    Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.